Name | MI 14 |
---|---|
Synonyms |
N-[2-({6-Chloro-3-[3-(dimethylsulfamoyl)phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl}amino)ethyl]acetamide
MFCD29081194 N-[2-[[6-Chloro-3-[3-[(dimethylamino)sulfonyl]phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide Acetamide, N-[2-[[6-chloro-3-[3-[(dimethylamino)sulfonyl]phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]- |
Description | MI 14 is a selective PI4KIIIβ inhibitor with IC50s of 54 nM, >100 μM, >100 μM for PI4KIIIβ, PI4KIIIα, PI4KIIα, respectively. MI 14 has antiviral activity against HCV 1b, CVB3, HRVM, HVC 2a[1]. |
---|---|
Related Catalog | |
Target |
PI4KIIIβ:54 nM (IC50) PI4KIIIα:>100 μM (IC50) PI4KIIα:>100 μM (IC50) |
In Vitro | MI 14 (化合物 36t) 对 HeLa 细胞中的 HCV 1b (EC50=0.087 µM)、CVB3 (EC50=0.145 µM)、HRVM (EC50=1.03 µM)、HVC 2a (EC50=10.6 µM) 具有抗病毒活性[1]。 MI 14 对磷脂酰肌醇 3 激酶 (PI3Ka、PI3Kb、PI3Kd 和 PI3Kg) 没有抑制作用,IC50 高达 10 µM[1]。 |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C19H23ClN6O3S |
Molecular Weight | 450.94 |
Exact Mass | 450.124084 |
LogP | 1.97 |
Index of Refraction | 1.661 |